January 28, 2019What's New
Editor's Note: Target Health has one of the top regulatory teams in the US and is pleased to say that even during the shutdown, not only did we have active interactions with our colleagues at FDA, we also had a pre-IND meeting and everyone from FDA attended. We want to congratulate the professionals at FDA for not missing a beat.
Target Health Inc. is pleased to announce that Dr. Jules T. Mitchel will be presenting a talk on Study Designs for Rare Diseases and Regulatory Considerations at American Conference on Advanced Treatments in Rare Diseases (RARE2019-USA), taking place on June 13-14, 2019 in East Brunswick, New Jersey, USA.
RARE2019-USA will follow on from the success of its European predecessor, addressing the challenges of Rare Diseases, their diagnosis and treatment as well as on new therapeutic modalities already in advanced stages of development. The Conference will expand on so-called generic topics, such as clinical trials' design, funding for research, digital health, big data on the one hand and focusing on the individual patients for innovation in both drug development and management.
The Conference will provide participants an excellent opportunity to interact with all faculty members, consult, exchange views and to build up new collaborations and networking
For more information about Target Health, contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors.
Joyce Hays, Founder and Editor in Chief of On Target
Jules Mitchel, Editor